Preclinical News and Research

RSS
Preclinical efficacy data of Sangamo's ZFN based human stem cell therapy for HIV published

Preclinical efficacy data of Sangamo's ZFN based human stem cell therapy for HIV published

Amorfix partners with reMYND to offer A4 amyloid testing services

Amorfix partners with reMYND to offer A4 amyloid testing services

CTI submits expanded PIP to EMEA for pixantrone MAA for relapsed or refractory, aggressive NHL

CTI submits expanded PIP to EMEA for pixantrone MAA for relapsed or refractory, aggressive NHL

Aushon BioSystems introduces new Human multiplex biomarker panels

Aushon BioSystems introduces new Human multiplex biomarker panels

China PharmaHub announces new joint venture for humanized antibody

China PharmaHub announces new joint venture for humanized antibody

Aptuit to acquire GSK's research business in Verona

Aptuit to acquire GSK's research business in Verona

Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions

Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions

Pre-clinical data of BiTE antibody technology published in PNAS

Pre-clinical data of BiTE antibody technology published in PNAS

CBio achieves recruitment milestone in XToll clinical trial

CBio achieves recruitment milestone in XToll clinical trial

Sanofi-aventis signs agreement to acquire TargeGen

Sanofi-aventis signs agreement to acquire TargeGen

Neuralstem announces completion of $10 million registered direct offering

Neuralstem announces completion of $10 million registered direct offering

Fero Industries closes acquisition of rights related to production, marketing and distribution of Sucanon

Fero Industries closes acquisition of rights related to production, marketing and distribution of Sucanon

Calistoga Pharmaceuticals closes $40 million Series C financing

Calistoga Pharmaceuticals closes $40 million Series C financing

Transition commences dosing in TT-301 Phase 1 clinical study for rheumatoid arthritis, ICH, TBI

Transition commences dosing in TT-301 Phase 1 clinical study for rheumatoid arthritis, ICH, TBI

Sangart completes enrollment for MP4OX Phase IIa study in severely injured trauma patients

Sangart completes enrollment for MP4OX Phase IIa study in severely injured trauma patients

Threshold Pharmaceuticals commences TH-302 Phase 1 clinical trial in patients with advanced leukemias

Threshold Pharmaceuticals commences TH-302 Phase 1 clinical trial in patients with advanced leukemias

Alnylam receives Portuguese, Swedish, British approvals to initiate ALN-TTR01 Phase I study in ATTR

Alnylam receives Portuguese, Swedish, British approvals to initiate ALN-TTR01 Phase I study in ATTR

Chelsea initiates NORTHERA Phase III trial for symptomatic NOH associated with PD

Chelsea initiates NORTHERA Phase III trial for symptomatic NOH associated with PD

International symposium to highlight current and future applications of MR-guided ultrasound

International symposium to highlight current and future applications of MR-guided ultrasound

Avila's AVL-292 demonstrates disease-modifying effects in prophylactic, therapeutic models of rheumatoid arthritis

Avila's AVL-292 demonstrates disease-modifying effects in prophylactic, therapeutic models of rheumatoid arthritis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.